Strome Investment Management L.P., 10% Owner at Zivo Bioscience, Inc. (ZIVO), bought 20,259 shares at $0.12 ($2K) on 2025-10-13, disclosed to the SEC on 2025-10-20.
Open-market purchase of $2k ZIVO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.